Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis
Sponsor: Sanofi
Summary
This is a prospective, 18-month observational study of adult, adolescent and pediatric Canadian participants with Atopic Dermatitis (AD) commonly known as Eczema, who receive treatment with Dupixent for moderate-to-severe AD (msAD) according to the Canadian-specific prescribing information (in accordance with the Canadian Dupixent Product Monograph). The study will be conducted in approximately 30 centers in Canada to assess participants of all ethnicities and races. At each participating site, all AD participants who receive an initial prescription for Dupixent will be invited to participate in this study, until the Canadian enrollment goal is achieved.
Official title: A Prospective, Observational Study of Canadian Patients Receiving Dupixent® for Moderate to Severe Atopic Dermatitis
Key Details
Gender
All
Age Range
6 Years - Any
Study Type
OBSERVATIONAL
Enrollment
305
Start Date
2023-10-10
Completion Date
2026-04-10
Last Updated
2025-03-18
Healthy Volunteers
No
Conditions
Locations (29)
Investigational Site Number : 1240019
Calgary, Alberta, Canada
Investigational Site Number : 1240021
Calgary, Alberta, Canada
Investigational Site Number : 1240009
Edmonton, Alberta, Canada
Investigational Site Number : 1240007
Edmonton, Alberta, Canada
Investigational Site Number : 1240028
Nanaimo, British Columbia, Canada
Investigational Site Number : 1240010
Surrey, British Columbia, Canada
Investigational Site Number : 1240029
Winnipeg, Manitoba, Canada
Investigational Site Number : 1240026
Fredericton, New Brunswick, Canada
Investigational Site Number : 1240020
Halifax, Nova Scotia, Canada
Investigational Site Number : 1240002
Ajax, Ontario, Canada
Investigational Site Number : 1240024
Barrie, Ontario, Canada
Investigational Site Number : 1240031
Cobourg, Ontario, Canada
Investigational Site Number : 1240011
Etobicoke, Ontario, Canada
Investigational Site Number : 1240016
London, Ontario, Canada
Investigational Site Number : 1240025
Newmarket, Ontario, Canada
Investigational Site Number : 1240008
Peterborough, Ontario, Canada
Investigational Site Number : 1240005
Richmond Hill, Ontario, Canada
Investigational Site Number : 1240033
Toronto, Ontario, Canada
Investigational Site Number : 1240030
Toronto, Ontario, Canada
Investigational Site Number : 1240014
Toronto, Ontario, Canada
Investigational Site Number : 1240018
Waterloo, Ontario, Canada
Investigational Site Number : 1240034
Whitby, Ontario, Canada
Investigational Site Number : 1240012
Montreal, Quebec, Canada
Investigational Site Number : 1240017
Montreal, Quebec, Canada
Investigational Site Number : 1240006
Pointe-Claire, Quebec, Canada
Investigational Site Number : 1240013
Québec, Quebec, Canada
Investigational Site Number : 1240023
Saint-Jean-sur-Richelieu, Quebec, Canada
Investigational Site Number : 1240003
Regina, Saskatchewan, Canada
Investigational Site Number : 1240027
Saskatoon, Saskatchewan, Canada